Curie Cancer Carnot Institute names Intel lead partner to implement high performance computing and artificial intelligence in accelerating genome sequencing and interpretation for oncology

07 2018
Les Carnot et les entreprises

Curie Cancer Carnot Institute and Intel initiate a pioneering collaboration to develop, use and implement innovative Bioinformatics tools, pipelines and techniques to improve the use of molecular profiling across both research and clinical oncology settings.

Read the press release